Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-03 4:41 pm Purchase | 13G | 10X GENOMICS INC TXG | BlackRock Inc. BLK | 8,018,634 8.8% | 2,855,614 (+55.31%) | View |
2022-01-18 06:57 am Purchase | 13G | 10X GENOMICS INC TXG | BAILLIE GIFFORD & CO | 6,878,377 7.51% | 6,878,377 (New Position) | View |
2021-12-10 08:52 am Sale | 13G | 10X GENOMICS INC TXG | FMR LLC | 13,746,514 14.059% | -2,915,302 (-17.50%) | View |
2021-07-30 5:04 pm Sale | 13D | 10X GENOMICS INC TXG | Hindson Benjamin J. | 3,611,410 4% | -438,590 (-10.83%) | View |
2021-07-30 5:01 pm Purchase | 13D | 10X GENOMICS INC TXG | Saxonov Serge | 4,851,530 5.3% | 123,879 (+2.62%) | View |
2021-02-16 4:17 pm Sale | 13G | 10X GENOMICS INC TXG | Meritech Capital Partners V L.P. | 2,580,975 3.2% | -1,079,979 (-29.50%) | View |
2021-02-16 4:06 pm Sale | 13G | 10X GENOMICS INC TXG | Venrock Associates VI L.P. | 7,828,247 9.1% | -3,263,569 (-29.42%) | View |
2021-02-16 10:34 am Sale | 13G | 10X GENOMICS INC TXG | Foresite Capital Fund I L.P. | 3,753,528 4.7% | -10,319,121 (-73.33%) | View |
2021-02-16 09:11 am Sale | 13G | 10X GENOMICS INC TXG | SB INVESTMENT ADVISERS (UK) LTD | 0 0% | -3,836,232 (Position Closed) | View |
2021-02-11 6:37 pm Sale | 13G | 10X GENOMICS INC TXG | Paladin Capital Management LLC | 2,165,199 2.7% | -6,509,968 (-75.04%) | View |
2021-02-10 10:30 am Purchase | 13G | 10X GENOMICS INC TXG | VANGUARD GROUP INC | 6,187,705 7.72% | 6,187,705 (New Position) | View |
2021-02-10 10:23 am Sale | 13G | 10X GENOMICS INC TXG | MORGAN STANLEY MS | 5,915,534 7.4% | -877,284 (-12.91%) | View |
2021-02-08 10:13 am Purchase | 13G | 10X GENOMICS INC TXG | FMR LLC | 16,661,816 19.207% | 4,520,624 (+37.23%) | View |
2021-02-02 3:13 pm Purchase | 13G | 10X GENOMICS INC TXG | BlackRock Inc. BLK | 5,163,020 6.4% | 5,163,020 (New Position) | View |
2020-05-11 08:45 am Purchase | 13G | 10X GENOMICS INC TXG | FMR LLC | 12,141,192 18.71% | 421,603 (+3.60%) | View |
2020-05-08 4:19 pm Purchase | 13G | 10X GENOMICS INC TXG | MORGAN STANLEY MS | 6,792,818 12.1% | 1,774,572 (+35.36%) | View |
2020-04-09 4:08 pm Purchase | 13G | 10X GENOMICS INC TXG | MORGAN STANLEY MS | 5,018,246 23.6% | 3,947,755 (+368.78%) | View |
2020-02-18 06:19 am Purchase | 13G | 10X GENOMICS INC TXG | Paladin Capital Management LLC | 8,675,167 29.3% | 8,675,167 (New Position) | View |
2020-02-14 5:29 pm Purchase | 13G | 10X GENOMICS INC TXG | SB INVESTMENT ADVISERS (UK) LTD | 3,836,232 15.5% | 3,836,232 (New Position) | View |
2020-02-14 4:05 pm Purchase | 13G | 10X GENOMICS INC TXG | Venrock Associates VI L.P. | 11,091,816 34.7% | 11,091,816 (New Position) | View |